dsdsa

product

2020 China New Design Mesylate-Azd9291 - High Purity Ready Stock 61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Using a complete scientific top quality management program, great high-quality and fantastic religion, we win great track record and occupied this area for Ruxolitinib Powder, 15663-27-1, 33069-62-4, We welcome new and old customers from all walks of life to contact us for future business relationships and mutual success!
2020 China New Design Mesylate-Azd9291 - High Purity Ready Stock 61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai Detail:

Product name Oxaliplatin
Synonyms trans-L-Diaminocyclohexane oxalatoplatinum
CAS No. 61825-94-3
Appearance White to off white crystallization powder
Molecular Formula C8H12N2O4Pt
Molecular Weight 395.27
Usage Pharmaceutical Grade or Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Oxaliplatin Cas: 61825-94-3

Items

Standard

Results

Appearance White or almost white crystalline powder White crystalline powder
Solubility Slightly soluble in water ,very slightly soluble in methanol, practically insoluble in anhydrous ethanol Complies
Identification   Spectrum of sample should consistent with spectrum of reference standard A.CompliesB.Complies
Apearance of solution The solution is clear and colourless Complies
Acidity Not more than 0.6ml of 0.01M NaOH is required to change the colour of the indicator to pink Complies
Specific optical rotation +74.5°~+78.0° +75.9°
Related substances ImpurityA:NMT0.10%ImpurityB: NMT0.10%

ImpurityC: NMT0.10%

Any other impurity:NMT0.10%

Total of other impurities: NMT0.10%

(include impurity C)                     

Total of impurities: NMT0.30%

ImpurityA: 0.04%  ImpurityB:0.01%ImpurityC: 0.001%

Any other impurities: 0.002%

Total of other impurities:

0.01%

Total of impurities: 0.03%

Impurity D NMT0.10% N.D
Silver NMT5.0ppm 0.08ppm
Loss on drying NMT0.5% 0.09%
Assay 98.0~102.0% (dried substance) 99.7%
Conclusion: The results show that the product complies with EP9.0

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

2020 China New Design Mesylate-Azd9291 - High Purity Ready Stock  61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai detail pictures

2020 China New Design Mesylate-Azd9291 - High Purity Ready Stock  61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai detail pictures

2020 China New Design Mesylate-Azd9291 - High Purity Ready Stock  61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai detail pictures


Related Product Guide:

Sticking for the principle of "Super Quality, Satisfactory service" ,We have been striving for being a superb small business partner of you for 2020 China New Design Mesylate-Azd9291 - High Purity Ready Stock 61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai , The product will supply to all over the world, such as: Italy, Bolivia, Cannes, Our products are very popular in the word, like South American, Africa, Asia and so on. Companies to "create first-class products" as the goal, and strive to deliver customers with high quality solutions, present high-quality after-sales service and technical support, and customer mutual benefit, create a better career and future!
  • We have worked with many companies, but this time is the best,detailed explanation, timely delivery and quality qualified, nice!
    5 Stars By Antonia from Munich - 2018.06.28 19:27
    After the signing of the contract, we received satisfactory goods in a short term, this is a commendable manufacturer.
    5 Stars By Olga from Karachi - 2017.08.16 13:39
    Write your message here and send it to us